Loading...

Novozymes A/S

NVZMY•PNK
Basic Materials
Chemicals - Specialty
$65.19
$0.20(0.31%)

Novozymes A/S (NVZMY) Financial Performance & Income Statement Overview

Review Novozymes A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-78.58%
↓ 78.58%
Operating Income Growth
-83.43%
↓ 83.43%
Net Income Growth
-89.89%
↓ 89.89%
Operating Cash Flow Growth
-75.44%
↓ 75.44%
Operating Margin
10.20%
↑ 10.20%
Gross Margin
43.95%
↑ 43.95%
Net Profit Margin
5.40%
↑ 5.40%
ROE
1.94%
↑ 1.94%
ROIC
12.30%
↑ 12.30%

Novozymes A/S (NVZMY) Income Statement & Financial Overview

Review Novozymes A/S's (NVZMY) income statement with detailed quarterly and annual figures.

MetricQ4 2024Q2 2024Q1 2024Q4 2023
Revenue$2.002B$6.83B$6.83B$4.60B
Cost of Revenue$959.30M$3.97B$3.97B$2.12B
Gross Profit$1.04B$2.86B$2.86B$2.48B
Gross Profit Ratio$0.52$0.42$0.42$0.54
R&D Expenses$218.70M$725.39M$725.43M$524.00M
SG&A Expenses$406.00M$1.34B$1.34B$842.00M
Operating Expenses$607.00M$2.36B$2.36B$1.42B
Total Costs & Expenses$1.57B$6.33B$6.33B$3.53B
Interest Income$0.00$0.00$0.00$30.00M
Interest Expense$0.00$0.00$0.00$120.00M
Depreciation & Amortization$0.00$292.31M$292.25M$145.00M
EBITDA$435.50M$1.13B$1.13B$1.04B
EBITDA Ratio$0.22$0.16$0.16$0.23
Operating Income$435.50M$503.49M$503.51M$1.53B
Operating Income Ratio$0.22$0.07$0.07$0.33
Other Income/Expenses (Net)-$108.40M-$167.83M-$167.84M-$32.00M
Income Before Tax$327.10M$335.66M$335.67M$923.00M
Income Before Tax Ratio$0.16$0.05$0.05$0.20
Income Tax Expense$85.20M$97.34M$97.35M$228.00M
Net Income$241.90M$238.32M$238.33M$698.00M
Net Income Ratio$0.12$0.03$0.03$0.15
EPS$0.53$0.86$0.86$2.52
Diluted EPS$0.53$0.86$0.86$2.51
Weighted Avg Shares Outstanding$456.42M$277.90M$277.90M$277.87M
Weighted Avg Shares Outstanding (Diluted)$456.42M$277.90M$277.90M$277.87M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;